Contact Us

Monoclonal Antibodies Experience

Expertise in Monoclonal Antibody Research

DiagnoSearch brings specialized expertise in managing monoclonal antibody (mAb) clinical trials across all phases, from first-in-human studies to post-marketing research. As a trusted global CRO for monoclonal antibody development and support, we understand the scientific, operational, and regulatory nuances of mAb programs in India and globally.

Therapeutic Areas Covered

Oncology
Breast Cancer, Colorectal Cancer, B-cell Lymphoma, Non-Small Cell Lung Cancer (NSCLC)
Gastroenterology
Ulcerative Colitis
Neurosciences
Multiple Sclerosis
Type 1 Diabetes
Rabies Post-Exposure Prophylaxis
Healthy Volunteer Studies

Monoclonal Antibody Trial Experience

  • 2,400+ participants enrolled
  • 240+ clinical trial sites managed
  • Experience across India, Australia, and New Zealand
  • Successful management of both innovator and biosimilar mAb trials

The DiagnoSearch Advantage

  • Proven expertise in biosimilar and innovator biologics
  • Multi-country clinical trial experience
  • Specialized in monoclonal antibodies for autoimmune diseases and oncology trials
  • Commitment to high-quality data and regulatory compliance
  • Seamless stakeholder coordination for faster trial execution
  • Rapid trial activation in Australia and New Zealand

DiagnoSearch combines strategic insight with on-ground experience to accelerate monoclonal antibody research programs, delivering precise, reliable, and compliant outcomes.